This page explains how LondonBridgeUrology.net produces its editorial content, how we fund this publication, and how we manage the potential conflict between commercial revenue and editorial independence.
How We Assess Products
Every supplement review published on this site follows the same editorial framework:
1. Ingredient-Level Evidence Review. We identify every active ingredient in a product’s formulation and examine the published clinical research for each one. We look for randomised controlled trials, systematic reviews, and meta-analyses — not manufacturer-funded white papers or testimonial evidence. When the only available evidence is preliminary (cell studies, animal models, small pilot trials), we say so explicitly.
2. Dosage Assessment. We compare the doses used in clinical studies to the doses present in the product. A clinically studied ingredient at a sub-clinical dose is, in our editorial assessment, not materially different from an unstudied ingredient. We flag this clearly.
3. Formulation Transparency. We assess whether a product discloses its full ingredient list with individual doses, or whether it hides behind proprietary blends. Products that do not disclose individual ingredient quantities receive a lower editorial assessment, because we cannot evaluate what we cannot verify.
4. Regulatory Context. For UK readers, we note whether products are available through UK retailers, comply with MHRA standards, and make health claims that align with the UK/EU approved health claims register. Products making unapproved health claims are flagged.
5. Value Assessment. We consider the product’s price relative to its formulation quality, with attention to UK pricing and availability where applicable.
How We Assess Telehealth Platforms
Telehealth reviews follow a parallel framework: we evaluate the platform’s prescribing model, clinical governance, pricing transparency, UK availability, user experience, and whether the service meets the needs it claims to serve. We do not evaluate clinical outcomes — that is beyond the scope of editorial assessment.
How We Fund This Publication
Affiliate Revenue: LondonBridgeUrology.net earns revenue through affiliate partnerships. When we link to a product or telehealth platform and you make a purchase or sign up through that link, we may earn a commission. This costs you nothing additional — the price is the same whether you use our link or go directly to the retailer.
What this means in practice: Our editorial content is commercially supported. We are transparent about this because we believe you deserve to know. The FTC (for US readers) and the ASA/CAP Code (for UK readers) require this disclosure, and we agree with the principle behind it.
Does affiliate revenue influence our editorial assessments? No. Our editorial assessments are based on the evidence framework described above. We have published unfavourable reviews of products with generous affiliate programmes, and favourable reviews of products with no affiliate relationship. The editorial judgment and the commercial relationship are separate functions.
Every article that contains affiliate links includes a disclosure notice at the top of the content, using the following language:
What We Are Not
We are not a medical publication in the clinical sense. Our content is not peer-reviewed by physicians. We do not employ doctors, urologists, or licensed healthcare professionals. Our editorial team consists of health content researchers and editors — not clinicians.
Nothing on this site constitutes medical advice. If you are experiencing urological symptoms, hormonal concerns, or any health issue, consult your GP or a qualified specialist. Our content is designed to inform your understanding of health products and services — not to replace the guidance of your healthcare provider.
Corrections and Accountability
If we get something wrong — a factual error, a misrepresented study, an outdated product formulation — we want to know. We publish corrections transparently and update articles when new evidence emerges. If you identify an error in our content, please contact us.